EBV mRNA vaccine

BIOLOGICAL3 trials

Sponsors

West China Hospital

Conditions

EBV-associated TumorsHIV Associated LymphomaMalignant Tumors

Early Phase 1

Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA Vaccine

Not yet recruitingNCT07563023

West China HospitalHIV Associated Lymphoma

Start: 2026-05-01End: 2028-12-31Target: 6Updated: 2026-05-01

Phase 1

Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors

Active, not recruitingNCT05714748

West China HospitalMalignant Tumors

Start: 2023-02-08End: 2025-05-31Target: 19Updated: 2025-06-04

Unknown Phase

The Application of mRNA Immunotherapy Technology in Refractory Malignancies Associated With Epstein-Barr Virus (EBV)

Not yet recruitingNCT07101536

West China HospitalEBV-associated Tumors

Start: 2025-08-01End: 2027-12-31Target: 40Updated: 2025-08-03

Related Papers

Safety, tolerability, and immunogenicity of WGc-043 in subjects with EBV-positive cancers: Results from an investigator-initiated trial.

Journal of Clinical Oncology2024-08-103 citations